Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Concomitant TP53 mutation in early-stage resected EGFR-mutated non-small cell lung cancer: a narrative approach in a genetically admixed Brazilian cohort.
Machado-Rugolo J, Baldavira CM, Prieto TG, Olivieri EHR, Fabro AT, Rainho CA, Castelli EC, Ribolla PEM, Ab'Saber AM, Takagaki T, Nagai MA, Capelozzi VL. Machado-Rugolo J, et al. Among authors: nagai ma. Braz J Med Biol Res. 2023 Apr 7;56:e12488. doi: 10.1590/1414-431X2023e12488. eCollection 2023. Braz J Med Biol Res. 2023. PMID: 37042869 Free PMC article.
Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer.
Machado-Rugolo J, Fabro AT, Ascheri D, Farhat C, Ab'Saber AM, de Sá VK, Nagai MA, Takagaki T, Terra R, Parra ER, Capelozzi VL. Machado-Rugolo J, et al. Among authors: nagai ma. Hum Pathol. 2019 Jan;83:177-191. doi: 10.1016/j.humpath.2018.08.026. Epub 2018 Sep 13. Hum Pathol. 2019. PMID: 30218756
Variants in Epithelial-Mesenchymal Transition and Immune Checkpoint Genes Are Associated With Immune Cell Profiles and Predict Survival in Non-Small Cell Lung Cancer.
Parra ER, Jiang M, Machado-Rugolo J, Yaegashi LB, Prieto T, Farhat C, de Sá VK, Nagai MA, de Lima VCC, Takagaki T, Terra R, Fabro AT, Capelozzi VL. Parra ER, et al. Among authors: nagai ma. Arch Pathol Lab Med. 2020 Oct 1;144(10):1234-1244. doi: 10.5858/arpa.2019-0419-OA. Arch Pathol Lab Med. 2020. PMID: 32150457 Free article.
Relevance of PD-L1 Non-Coding Polymorphisms on the Prognosis of a Genetically Admixed NSCLC Cohort.
Machado-Rugolo J, Gutierrez Prieto T, Fabro AT, Parra Cuentas ER, Sá VK, Baldavira CM, Rainho CA, Castelli EC, Farhat C, Takagaki TY, Nagai MA, Capelozzi VL. Machado-Rugolo J, et al. Among authors: nagai ma. Pharmgenomics Pers Med. 2021 Feb 15;14:239-252. doi: 10.2147/PGPM.S286717. eCollection 2021. Pharmgenomics Pers Med. 2021. PMID: 33623414 Free PMC article.
Circulating Plasma miRNA and Clinical/Hemodynamic Characteristics Provide Additional Predictive Information About Acute Pulmonary Thromboembolism, Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Hypertension.
Fabro AT, Machado-Rugolo J, Baldavira CM, Prieto TG, Farhat C, Rotea ManGone FR, Batah SS, Cruvinel HR, Aldá MA, Monteiro JS, Pádua AI, Morais SS, Antônio de Oliveira R, Santos MK, Baddini-Martinez JA, Setubal JC, Rainho CA, Yoo HHB, Silva PL, Nagai MA, Capelozzi VL. Fabro AT, et al. Among authors: nagai ma. Front Pharmacol. 2021 May 28;12:648769. doi: 10.3389/fphar.2021.648769. eCollection 2021. Front Pharmacol. 2021. PMID: 34122072 Free PMC article.
Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor.
Machado-Rugolo J, Baldavira CM, Prieto TG, Olivieri EHR, Fabro AT, Rainho CA, Castelli EC, Ribolla PEM, Ab'Saber AM, Takagaki T, Nagai MA, Capelozzi VL. Machado-Rugolo J, et al. Among authors: nagai ma. Braz J Med Biol Res. 2023 Jan 9;55:e12409. doi: 10.1590/1414-431X2022e12409. eCollection 2023. Braz J Med Biol Res. 2023. PMID: 36629526 Free PMC article.
The Immunological Landscape of M1 and M2 Macrophages and Their Spatial Distribution in Patients with Malignant Pleural Mesothelioma.
Laberiano-Fernandez C, Baldavira CM, Machado-Rugolo J, Tamegnon A, Pandurengan RK, Ab'Saber AM, Balancin ML, Takagaki TY, Nagai MA, Capelozzi VL, Parra ER. Laberiano-Fernandez C, et al. Among authors: nagai ma. Cancers (Basel). 2023 Oct 24;15(21):5116. doi: 10.3390/cancers15215116. Cancers (Basel). 2023. PMID: 37958292 Free PMC article.
95 results